Sudarshan Pharma Q4 FY26: Revenue up, profit jumps

April 30, 2026 3 mins read Firehose Gupta

SUDARSHAN PHARMA INDUSTRIES LIMITED — Quarter and year ended 31st March, 2026

BSE Scrip Code:	543828
BSE Trading Symbol:	SUDARSHAN
ISIN:	INE00TV01023

Sr. No.	Particulars	Quarter ended 31-Mar-26 Refer note 2	31-Dec-25 Un-Audited	31-Mar-25 Refer note 2	Year Ended 31-Mar-26 Audited	31-Mar-25 Audited
I	INCOME
I	Revenue from operations	19,980.98	15,837.13	16,156.81	66,749.85	50,249.34
II	Other Income	320.79	168.96	91.11	840.44	299.88
III	Total Income (I + II)	20,301.77	16,006.09	16,247.91	67,590.29	50,549.22
IV	EXPENSES
(a)	Cost of Materials Consumed	105.65	58.15	298.75	297.68	399.90
(b)	Purchase of Stock-in-Trade	19,356.54	15,177.88	16,445.88	65,599.01	48,859.26
(c)	Changes in inventories of finished goods, work-in-progress & Stock-in-Trade	(2,328.75)	(1,365.11)	(2,797.48)	(7,063.44)	(5,330.06)
(d)	Employee Benefit Expenses	184.80	167.97	123.97	618.97	451.84
(e)	Finance Costs	727.39	624.17	444.26	2,529.74	1,621.53
(f)	Depreciation and Amortization Expense	100.36	80.63	75.55	340.65	270.18
(g)	Other Expenses	832.40	720.86	564.76	2,400.87	2,114.22
Total Expenses (IV (a to g))	18,978.40	15,464.55	15,155.68	64,723.48	48,386.88
V	Profit before exceptional and extraordinary items and tax	1,323.37	541.55	1,092.23	2,866.82	2,162.34
	Exceptional Items	–	–	164.84	–	281.73
VI	Profit before extraordinary items and tax	1,323.37	541.55	927.39	2,866.82	1,880.61
	Extraordinary items	–	–	–	–	–
VII	Profit before tax	1,323.37	541.55	927.39	2,866.82	1,880.61
VIII	Tax expense:
(a)	Current tax	340.65	135.01	253.75	709.31	539.65
(b)	Deferred tax (Expense) / Income	53.83	(24.01)	(29.05)	(15.27)	(52.04)
(c)	Tax for Earlier Year	(25.39)	–	–	(25.39)	(9.16)
	Total Tax Expenses	369.09	111.00	224.71	668.65	478.45
IX	Net Profit/(Loss) for the year from continuing operations	954.28	430.54	702.68	2,198.16	1,402.16
	Net Profit/(Loss) for the year	954.28	430.54	702.68	2,198.16	1,402.16
X	Other comprehensive income, net of income tax
i)	items that will not be reclassified to profit or loss	5.53	(1.16)	(1.16)	2.04	(4.65)
ii)	income tax relating to items that will not be reclassified to profit or loss	(1.39)	0.29	0.29	(0.51)	1.17
	Total other comprehensive income, net of income tax	4.14	(0.87)	(0.87)	1.53	(3.48)
XI	Total comprehensive income for the period/year (7+8)	958.42	429.67	701.81	2,199.69	1,398.68
XII	Paid up Equity Share Capital (Face Value of Equity Shares Rs.10/- each)	2,406.59	2,406.59	2,406.59	2,406.59	2,406.59
XIII	Reserve Excluding Revaluation Reserve	–	–	–	12,863.92	10,664.23
XIV	Earning per share (in Rs) from Continuing Operations:
(i)	Basic EPS	0.40	0.18	0.29	0.91	0.58
(ii)	Diluted EPS	0.39	0.18	0.29	0.90	0.58

PARTICULARS	31-Mar-26 Audited	31-Mar-25 Audited
Assets
Non-current assets
Property, plant and equipment	7,276.85	3,007.44
Capital work-in-progress	343.51	2,253.98
Investment properties	1,151.66	1,192.80
Intangible assets	996.75	33.06
Financial assets
Investments	775.40	317.21
Loans	–	–
Other financial assets	3,125.84	869.19
Deferred tax assets	19.39	4.64
Other non-current assets	1,254.07	–
Total non-current assets	14,943.47	7,678.318
Current assets
Inventories	20,665.52	13,704.09
Financial assets
Investments	–	166.91
Trade receivables	19,922.85	15,207.74
Loans	268.84	542.17
Cash and cash equivalents	10.90	38.86
Other financial assets	972.18	641.64
Other current assets	2,634.21	2,342.95
Total current assets	44,474.50	32,644.35
Total assets	59,417.97	40,322.67
Equity and liabilities
Equity
Equity share capital	2,406.59	2,406.59
Other equity	12,863.92	10,664.23
Total equity	15,270.51	13,070.82
Liabilities
Non-current liabilities
Financial liabilities
Borrowings	3,039.26	1,042.91
Lease liabilities	51.31	263.64
Other financial liabilities	33.27	33.27
Provisions	18.83	14.88
Total non-current liabilities	3,142.68	1,354.69
Current liabilities
Financial liabilities
Borrowings	25,069.68	16,259.06
Lease liabilities	88.11	98.67
Trade payables
Total outstanding dues of micro enterprises and small enterprises	5,771.41	3,417.67
Total outstanding dues of creditors other than micro enterprises and small enterprises	8,940.13	5,398.54
Other financial liabilities	14.86	116.53
Current Tax liabilities	664.34	509.73
Employee benefit obligations	1.57	1.24
Other current liabilities	454.67	95.70
Total current liabilities	41,004.78	25,897.15
Total liabilities	44,147.46	27,251.85
Total equity and liabilities	59,417.97	40,322.67

Sr. No	PARTICULARS	31-Mar-26 Audited	31-Mar-25 Audited
A.	Cash Flows From Operating Activities
	Net Profit before Tax and After Exceptional Items	2,866.82	1,880.61
	Adjustments for:
	Exceptional Items	–	281.73
	Depreciation and amortisation expense	340.65	270.18
	Finance costs	2,529.74	1,571.70
	Provision for doubtful debts	39.72	195.42
	Gain on sale of assets	(102.01)	–
	Gain on early termination of lease	(18.49)	–
	Unrealised Foreign exchange gain (net)	(184.77)	–
	Realised/Unrealised gain on Mutual Funds	(8.38)	(11.08)
	Interest Income	(222.83)	(92.21)
	Operating Cash Generated Before Working Capital Changes	5,240.44	4,096.35
	(Increase) / Decrease in Inventory	(6,961.43)	(5,267.54)
	(Increase)/ Decrease in Trade Receivables	(4,754.84)	(3,655.22)
	(Increase)/Decrease in Other financial assets	715.45	(635.60)
	(Increase)/Decrease in other current assets	(291.26)	(266.22)
	Increase/(Decrease) in Trade Payables	6,080.11	2,798.21
	Increase/(Decrease) in Other current liabilities	256.03	(106.12)
	Increase / (Decrease) in Short Term Provision	2.38	(4.28)
	Increase / (Decrease) in Long Term Provision	3.96	6.85
	Net Changes in working capital	290.82	(3,033.57)
	Less : Tax	(566.04)	(284.13)
	Net Cash Flow from Operating Activities (A)	(275.22)	(3,317.70)
B.	Cash Flows From Investing Activities
	Sale / (Purchase) of Fixed Assets and intangible assets (Including capital advances)	(6,909.43)	(53.19)
	(Increase) / Decrease in Capital Work in Progress	1,910.47	(2,065.94)
	Investment in Subsidiary Company	–	(6.59)
	Payment for Investment in subsidiary	(456.92)	(0.70)
	Proceeds from sale of intangible assets	114.94	–
	Fixed deposits placed	(2,969.99)	–
	Fixed and Corporate Deposits matured	–	10.03
	Proceeds from sale of Mutual Funds	175.29	–
	Interest Income	164.51	92.21
	Net Cash Generated From Investing Activities (B)	(7,971.15)	(2,024.18)
C.	Cash Flow From Financing Activities
	Payments of lease liabilities (principal)	(95.56)	(73.92)
	Payment of lease liability (Interest)	(28.46)	(23.48)
	Proceeds / (Repayment) of Non-current Borrowings	1,996.36	(1.30)
	Proceeds/ (Repayment) in current borrowings	8,807.73	6,607.84
	Payment Received Towards Share Warrant	–	382.12
	Finance costs paid	(2,461.66)	(1,523.64)
	Net Cash from Financing Activities [C]	8,218.41	5,367.62
	Net Increase / (Decrease) in Cash and Cash Equivalents (A+B+C)	(27.96)	25.74
	Opening Balance of Cash & Cash Equivalents	38.86	13.12
	Closing Balance of Cash & Cash Equivalents	10.90	38.86

More from the same coverage lane.

Copy-Paste Quarterly Results have moved to Perivis Playbooks

Ashika Credit Capital: Investments jump to ₹97.76 lakh

Balmer Lawrie Q4 FY26 Revenue Rose to ₹74.0B